» Articles » PMID: 34928372

Development of 3D Printed Drug-eluting Contact Lenses

Overview
Specialties Pharmacology
Pharmacy
Date 2021 Dec 20
PMID 34928372
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of the work was to introduce 3D printing technology for the design and fabrication of drug-eluting contact lenses (DECL) for the treatment of glaucoma. The development of 3D printed lenses can effectively overcome drawbacks of existing approaches by using biocompatible medical grade polymers that provide sustained drug release of timolol maleate for extended periods.

Methods: Hot melt extrusion was coupled with fusion deposition modelling (FDM) to produce printable filaments of ethylene-vinyl acetate copolymer-polylactic acid blends at various ratios loaded with timolol maleate. Physicochemical and mechanical characterisation of the printed filaments was used to optimise the printing of the contact lenses.

Key Findings: 3D printed lenses with an aperture (opening) and specified dimensions could be printed using FDM technology. The lenses presented a smooth surface with good printing resolution while providing sustained release of timolol maleate over 3 days. The findings of this study can be used for the development of personalised DECL in the future.

Citing Articles

Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies.

Giri B, Jakka D, Sandoval M, Kulkarni V, Bao Q Pharmaceutics. 2024; 16(10).

PMID: 39458654 PMC: 11511072. DOI: 10.3390/pharmaceutics16101325.


Manufacturing and characterisation of 3D-printed sustained-release Timolol implants for glaucoma treatment.

Paleel F, Qin M, Tagalakis A, Yu-Wai-Man C, Lamprou D Drug Deliv Transl Res. 2024; 15(1):242-252.

PMID: 38578377 PMC: 11614933. DOI: 10.1007/s13346-024-01589-8.


Towards Precision Ophthalmology: The Role of 3D Printing and Bioprinting in Oculoplastic Surgery, Retinal, Corneal, and Glaucoma Treatment.

Wu K, Tabari A, Mazerolle E, Tran S Biomimetics (Basel). 2024; 9(3).

PMID: 38534830 PMC: 10968161. DOI: 10.3390/biomimetics9030145.


Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma.

Maulvi F, Patel A, Shetty K, Desai D, Shah D, Willcox M Drug Deliv Transl Res. 2024; 14(11):3212-3224.

PMID: 38407770 DOI: 10.1007/s13346-024-01543-8.


Technological Advances in a Therapy of Primary Open-Angle Glaucoma: Insights into Current Nanotechnologies.

Zembala J, Forma A, Zembala R, Januszewski J, Zembala P, Adamowicz D J Clin Med. 2023; 12(18).

PMID: 37762739 PMC: 10531576. DOI: 10.3390/jcm12185798.